Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

€46mm in Series C round for mtm

Executive Summary

Cervical cancer diagnostics developer mtm laboratories raised €22mm ($27.7mm) in its Series C financing. HBM BioVentures and HBM BioCapital led the round and were joined by Heidelberg Innovation and Wellington Partners, as well as new investors Nexus Medical Partners and SwissFirst Bank.
Deal Industry
  • Biotechnology
  • In Vitro Diagnostics
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies